Funded Projects

Birge, Welsh & Peng Receive $200,000 Under the Rutgers Optimizes Innovation Initiative Established with National Institutes of Health REACH Funding

HealthAdvance™ announces its inaugural award to advance the commercialization of anti-cancer therapeutics being developed by researchers Raymond B. Birge from New Jersey Medical School and William Welsh from Robert Wood Johnson Medical School, in collaboration with Youyi Peng at the Rutgers Cancer Institute of New Jersey. Guided by advanced in silico drug design tools, the research team will use the award for developing a series of first-in-class oncology drugs known as pan-TAM (Tyro3, Axl, Mertk) kinase inhibitors, expected to possess dual modes of action.

Read more